Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Return on Equity [ROE] (2021 - 2026)

Updated

Context Therapeutics (CNTX) posted Return on Equity [ROE] of -127.57% for Q3 2026, down 93.47 percentage points from -34.10% a year earlier and down 25.17 percentage points from the prior quarter.

Analysis

Context Therapeutics (CNTX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Context Therapeutics' Return on Equity [ROE] came in at -46.65%, up 3.24 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a four-year change of +20.91 percentage points (FY2021 to FY2025).
  • In prior years, Context Therapeutics' Return on Equity [ROE] was -49.89% in FY2024 (+52.66 pp), -102.55% in FY2023 (-65.50 pp), -37.05% in FY2022 (+30.51 pp) and -67.56% in FY2021.
  • The Q3 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2024.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last six quarters, with an average year-over-year change of +11.78 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 187.69 percentage points; the weakest was Q1 2024, with a drop of 158.75 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -102.40% (Q2 2026), -72.02% (Q1 2026) and -54.36% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -1,456.09%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 74.39%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 19.33%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 5.63%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 72.13%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -31.17%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -127.57%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -127.57%
Jun 30, 2026 -102.40%
Mar 31, 2026 -72.02%
Dec 31, 2025 -54.36%
Sep 30, 2025 -34.10%
Jun 30, 2025 -39.45%
Mar 31, 2025 -29.66%
Dec 31, 2024 -29.84%
Sep 30, 2024 -32.77%
Jun 30, 2024 -34.75%
Mar 31, 2024 -217.36%
Dec 31, 2023 -165.74%
Sep 30, 2023 -103.90%
Jun 30, 2023 -75.43%
Mar 31, 2023 -58.61%
Dec 31, 2022 -42.24%
Sep 30, 2022 -36.01%
Jun 30, 2022 -27.29%
Mar 31, 2022 -27.53%
Dec 31, 2021 -84.53%
API Access

Context Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CNTX&period=max&api_key=YOUR_API_KEY